Iodoacetylated and biotinylated liposomes: effect of spacer length on sulfhydryl ligand binding and avidin precipitability.
Because of the sustained interest in liposomes as immunogens and vehicles for drug delivery, the present investigation was designed to reevaluate the iodoacetyl group as a means of binding sulfhydryl-containing substances to liposomes in thioether linkage, and to develop an alternative method by which liposomes with bound ligand can be conveniently and rapidly separated from free ligand. For the purpose of the first goal, we synthesized a homologous series of dimyristoylphosphatidylethanolamine (DMPE) derivatives in which the iodoacetyl (IA) function was separated from the phospholipid amino group by either 0, 1, or 2 aminoethylthioacetyl (AETA) spacers. Results show that liposomes prepared with IA-DMPE can not bind 125I-radiolabeled rabbit IgG which had been thiolated by reaction with S-acetylmercaptosuccinic anhydride. Significant IgG attachment was, however, obtained with liposomes containing either IA-AETA-DMPE or IA-(AETA)2-DMPE, and the amount bound was directly related to spacer length. In contrast, spacer length had no effect on the covalent binding of a low molecular weight hapten, N-dinitrophenylcysteine. Other parameters (incubation time, IgG concentration, density of IA-(AETA)2-DMPE, sulfhydryl inhibitors) were also examined. To achieve the second objective, biotinyl-(AETA)2-DMPE was incorporated into the same liposomal bilayers that contained the iodoacetylated derivatives. Thus, liposomes with bound ligand could be readily precipitated by avidin, and washed free of unreacted IgG by low speed centrifugation. Comparative experiments with liposomes containing biotinyl-DMPE revealed that spacer length also had a pronounced effect on the avidin precipitability of liposomes in the presence of proteins that may be non-covalently absorbed or covalently bound to the model membrane surface.
D001360:Avidin / Q000494:pharmacology*; D001710:Biotin; D011232:Chemical Precipitation; D007074:Immunoglobulin G / Q000378:metabolism; D007461:Iodoacetates; D019807:Iodoacetic Acid; D008024:Ligands; D008081:Liposomes / Q000378:metabolism*; D008727:Methotrexate / Q000378:metabolism; D010047:Ovalbumin / Q000031:analogs & derivatives*; D010714:Phosphatidylethanolamines / Q000378:metabolism; D013329:Structure-Activity Relationship; D013438:Sulfhydryl Compounds / Q000378:metabolism*
D007074:Immunoglobulin G; D007461:Iodoacetates; D008024:Ligands; D008081:Liposomes; D010714:Phosphatidylethanolamines; D013438:Sulfhydryl Compounds; D001360:Avidin; D001710:Biotin; D010047:Ovalbumin; D019807:Iodoacetic Acid; D008727:Methotrexate; C018525:1,2-dimyristoylphosphatidylethanolamine